Maven Securities’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-90,000
| Closed | -$539K | – | 327 |
|
|
2023
Q4 | $539K | Buy |
+90,000
| New | +$539K | 0.01% | 144 |
|
|
2021
Q1 | – | Sell |
-65,000
| Closed | -$488K | – | 811 |
|
|
2020
Q4 | $488K | Buy |
+65,000
| New | +$488K | 0.05% | 338 |
|
|
2020
Q3 | – | Sell |
-150,000
| Closed | -$714K | – | 378 |
|
|
2020
Q2 | $714K | Buy |
+150,000
| New | +$714K | 0.05% | 99 |
|
|
2020
Q1 | – | Sell |
-1,118,593
| Closed | -$3.65M | – | 151 |
|
|
2019
Q4 | $3.65M | Buy |
+1,118,593
| New | +$3.65M | 0.33% | 19 |
|